TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH SHORT INTENSIVE CHEMOTHERAPY (MACOP-B)

被引:0
|
作者
DELMER, A [1 ]
BAUDUER, F [1 ]
RUSKONEFOURMESTRAUX, A [1 ]
AJCHENBAUMCYMBALISTA, F [1 ]
DELMASMARSALET, B [1 ]
RIO, B [1 ]
MARIE, JP [1 ]
ZITTOUN, R [1 ]
机构
[1] HOP HOTEL DIEU,SERV GASTROENTEROL,F-75181 PARIS 04,FRANCE
关键词
NON-HODGKINS LYMPHOMA; LARGE CELL; CHEMOTHERAPY; TOXICITY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We present our results of a MACOP-B regimen in a series of 46 patients with high-grade NHL. The complete remission rate was 74%for patients with advanced stage disease. The excellent tolerance allowed this regimen to be given on an outpatient basis in the majority of cases. The median follow-up for the living patients is 28 months. Although some patients received additional treatment that could influence the results, the predicted DFS (disease-free survival) at 45 months of 57% compares favorably with the best results published so far with more toxic regimens.
引用
收藏
页码:808 / 815
页数:8
相关论文
共 50 条
  • [1] MACOP-B TREATMENT FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS AT DIAGNOSIS AND IN RELAPSE
    TARELLA, C
    GALLO, E
    FERRERO, D
    BADONI, R
    CARLESSO, N
    CARACCIOLO, D
    PILERI, A
    HAEMATOLOGICA, 1990, 75 (02) : 149 - 154
  • [2] MACOP-B VS F-MACHOP IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    TURA, S
    MANDELLI, F
    MAZZA, P
    PILERI, S
    GHERLINZONI, F
    BOCCHIA, M
    ZINZANI, PL
    FIACCHINI, M
    MARTELLI, M
    PAPA, G
    ANTIMI, M
    MARTELLI, MF
    GRIGNANI, F
    FALINI, B
    CALABRESI, F
    RUGGERI, EM
    DAMMACCO, F
    LAUTA, VM
    LUCARELLI, G
    MORETTI, L
    LEUKEMIA, 1991, 5 : 74 - 78
  • [3] MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    MAZZA, P
    ZINZANI, PL
    MARTELLI, M
    FIACCHINI, M
    BOCCHIA, M
    PILERI, S
    FALINI, B
    MARTELLI, MF
    AMADORI, S
    PAPA, G
    CANTONETTI, M
    LUCARELLI, G
    MORETTI, L
    CALABRESI, F
    RUGGERI, E
    GHERLINZONI, F
    BENDANDI, M
    GUGLIELMI, C
    BURGIO, V
    DAMMACCO, F
    LAUTA, VM
    LIBERATI, AM
    MANDELLI, F
    TURA, S
    LEUKEMIA & LYMPHOMA, 1995, 16 (5-6) : 457 - 463
  • [4] INTENSIVE TREATMENT OF AIDS-RELATED NON-HODGKINS-LYMPHOMAS WITH THE MACOP-B PROTOCOL
    SCHURMANN, D
    GRUNEWALD, T
    WEISS, R
    JAUTZKE, G
    POHLE, HD
    RUF, B
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (02) : 73 - 77
  • [5] INTENSIVE CHEMOTHERAPY REGIMEN IN HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    ZINZANI, PL
    GHERLINZONI, F
    LAURIA, F
    MAZZA, P
    BARBIERI, E
    EMILIANI, E
    TABANELLI, M
    TURA, S
    TUMORI, 1987, 73 (02) : 121 - 126
  • [6] TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    JAGER, U
    DELLEKARTH, G
    KNAPP, S
    TUENI, C
    WIENER KLINISCHE WOCHENSCHRIFT, 1994, 106 (10) : 315 - 320
  • [7] CHEMOTHERAPY OF INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    CONSTANTOULAKIS, M
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 659 - 661
  • [8] MACOP-B CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE LYMPHOMAS IN PATIENTS WITH HIV-1 INFECTION
    TAILLAN, B
    GARNIER, G
    FERRARI, E
    PESCE, A
    VINTI, H
    FUZIBET, JG
    DUJARDIN, P
    ACTA HAEMATOLOGICA, 1993, 89 (01) : 10 - 12
  • [9] THE HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    JOHNSON, PWM
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1995, 53 (1-2) : 14 - 19
  • [10] MACOP-B CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE AND INTERMEDIATE GRADE NONHODGKINS LYMPHOMA
    OSTER, W
    FORSTHUBER, T
    HENNEKEUSER, HH
    GAMM, H
    LINDEMANN, A
    SCHMITZ, G
    FUHR, HG
    HINTERBERGER, R
    KREITER, H
    THOENES, W
    HERRMANN, F
    MERTELSMANN, R
    BLUT, 1990, 60 (01): : 23 - 27